The Evidence Based Rheumatology Podcast
E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
2019-10-03
This week I revisit an old paper - the 2013 ADACTA trial that assessed tocilizumab and adalimumab for patients who cannot take or were intolerant of MTX.
Comments (3)
More Episodes
All Episodes>>You may also like
Get this podcast on your phone, Free
Create Your Podcast In Minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Distribute to Apple Podcasts, Spotify, and more
- Make money with your podcast
It is Free
